Paradoxical ulcerative colitis during treatment with secukinumab for psoriasis

被引：14

作者：

Uchida, Shusuke ^{[1
]}

Oiso, Naoki ^{[1
]}

Komeda, Yoriaki ^{[2
]}

Kudo, Masatoshi ^{[2
]}

Kawada, Akira ^{[1
]}

机构：

[1] Kindai Univ, Dept Dermatol, Fac Med, Osaka, Japan

[2] Kindai Univ, Dept Gastroenterol & Hepatol, Fac Med, Osaka, Japan

来源：

EUROPEAN JOURNAL OF DERMATOLOGY | 2019年 / 29卷 / 04期

关键词：

THERAPY; CELLS;

D O I：

10.1684/ejd.2018.3391

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：444 / 445

页数：2

共 10 条

[1] TNF-α inhibitors reduce the pathological Th1-Th17/Th2 imbalance in cutaneous mesenchymal stem cells of psoriasis patients [J].

Campanati, Anna ;

Orciani, Monia ;

Lazzarini, Raffaella ;

Ganzetti, Giulia ;

Consales, Veronica ;

Sorgentoni, Giulia ;

Di Primio, Roberto ;

Offidani, Annamaria .

EXPERIMENTAL DERMATOLOGY, 2017, 26 (04) :319-324

[2] Linear IgA Bullous Dermatosis Secondary to Infliximab Therapy in a Patient with Ulcerative Colitis [J].

Hoffmann, Jochen ;

Hadaschik, Eva ;

Enk, Alexander ;

Stremmel, Wolfgang ;

Gauss, Annika .

DERMATOLOGY, 2015, 231 (02) :112-115

[3] Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial [J].

Hueber, Wolfgang ;

Sands, Bruce E. ;

Lewitzky, Steve ;

Vandemeulebroecke, Marc ;

Reinisch, Walter ;

Higgins, Peter D. R. ;

Wehkamp, Jan ;

Feagan, Brian G. ;

Yao, Michael D. ;

Karczewski, Marek ;

Karczewski, Jacek ;

Pezous, Nicole ;

Bek, Stephan ;

Bruin, Gerard ;

Mellgard, Bjoern ;

Berger, Claudia ;

Londei, Marco ;

Bertolino, Arthur P. ;

Tougas, Gervais ;

Travis, Simon P. L. .

GUT, 2012, 61 (12) :1693-1700

[4] Paradoxical ulcerative colitis during adalimumab treatment of psoriasis resolved by switch to ustekinumab [J].

Kolios, A. G. A. ;

Biedermann, L. ;

Weber, A. ;

Navarini, A. A. ;

Meier, J. ;

Cozzio, A. ;

French, L. E. .

BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) :551-555

[5]

Kotb IS, 2018, BR J DERMATOL

[6] Biologics-induced autoimmune diseases [J].

Perez-Alvarez, Roberto ;

Perez-de-Lis, Marta ;

Ramos-Casals, Manuel .

CURRENT OPINION IN RHEUMATOLOGY, 2013, 25 (01) :56-64

[7] Psoriasis induced by anti-tumor necrosis factor therapy - A paradoxical adverse reaction [J].

Sfikakis, PP ;

Iliopoulos, A ;

Elezoglou, A ;

Kittas, C ;

Stratigos, A .

ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2513-2518

[8] Th17 plasticity and its relevance to inflammatory bowel disease [J].

Ueno, Aito ;

Jeffery, Louisa ;

Kobayashi, Taku ;

Hibi, Toshifumi ;

Ghosh, Subrata ;

Jijon, Humberto .

JOURNAL OF AUTOIMMUNITY, 2018, 87 :38-49

[9] Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis [J].

van de Kerkhof, Peter C. M. ;

Griffiths, Christopher E. M. ;

Reich, Kristian ;

Leonardi, Craig L. ;

Blauvelt, Andrew ;

Tsai, Tsen-Fang ;

Gong, Yankun ;

Huang, Jiaqing ;

Papavassilis, Charis ;

Fox, Todd .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (01) :83-+

[10] Regulatory T cells promote a protective Th17-associated immune response to intestinal bacterial infection with C. rodentium [J].

Wang, Z. ;

Friedrich, C. ;

Hagemann, S. C. ;

Korte, W. H. ;

Goharani, N. ;

Cording, S. ;

Eberl, G. ;

Sparwasser, T. ;

Lochner, M. .

MUCOSAL IMMUNOLOGY, 2014, 7 (06) :1290-1301

← 1 →